This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Classical activation of the complement cascade

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

When IgG or IgM antibodies bind to an antigen on the surface of a bacterium or virally-infected cell, the immune complex formed interacts with the early complement components:

  • C1q binds to the antigen-antibody complex and is thus activated
  • C1r and C1s subunits then bind with C1q, are activated and the whole complex cleaves both C4 and C2
  • C4 is split into C4a and C4b
  • C2 is split into C2a and C2b
  • C4b binds to the target cell membrane and forms a complex with C2b
  • the C4b/C2b complex cleaves C3
  • C3 is converted to C3a and C3b
  • C3b forms a complex with C4b/C2b to cleave C5
  • C5 is converted to C5a and C5b
  • C5b binds to the target cell membrane and sequentially binds C6 to C9

The complex of C5b to C9 within the cell membrane is the membrane attack complex (MAC), a circular pore which damages the target cell. A number of the components produced in the pathway have independent roles in inflammation.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.